Mastering Hospital Billing for Cardiac PET/CT: Key Takeaways and Tips
Navigating the world of hospital billing for cardiac positron emission tomography (PET) and computed tomography (CT) scans can be incredibly challenging—even for experienced healthcare professionals. At the American Society of Nuclear Cardiology’s (ASNC) 2024 annual meeting, industry leaders provided clarity on important issues, from CMS methodologies and fluctuating reimbursement rates to the ongoing advocacy efforts aimed at improving coverage. Below is a closer look at what you need to know.
The Role of CMS and Hospital-Reported Data
One of the central themes highlighted at the meeting was how the Centers for Medicare and Medicaid Services (CMS) relies on hospital-reported data to determine payment rates for cardiac PET/CT scans. CMS collects charge data from Medicare claims, then uses a cost-to-charge ratio to approximate the real costs of procedures. These figures guide reimbursement rates directly.
“CMS depends heavily on hospitals to report their costs correctly,” explains Georgia Lawrence, JD, director of ASNC’s Institute for the Advancement of Nuclear Cardiology and Regulatory Affairs. Inaccurate data submission can lead to skewed reimbursement rates, which is why Lawrence underscored the importance of close collaboration between clinical and administrative teams.
New Technology Classification for Cardiac PET/CT
Although PET technology has been in clinical use for years, cardiac PET/CT billing codes were only introduced in 2020. These codes fall under new technology ambulatory payment classifications (APCs), a temporary category that allows CMS to collect cost data before transitioning the codes to standard APC groupings.
Given this classification, hospitals must pay close attention to how they document and submit cost data. Any discrepancy can lead to significant shifts in future payment structures, which is why ongoing education and interdepartmental communication are key.
Overcoming Challenges in Reimbursement and Coverage
Despite growing evidence supporting PET for analyzing myocardial blood flow, several private insurers still label PET blood flow as experimental or investigational. This discrepancy can lead to coverage denials, creating hurdles for hospitals and patients alike.
ASNC continues to advocate for broader coverage, pointing to numerous studies that confirm the utility and accuracy of PET imaging in cardiac care. Clinicians play a vital role in these advocacy efforts by contributing data and sharing clinical outcomes that highlight PET’s benefits.
Navigating Prior Authorization Reforms
Prior authorization has traditionally been a time-consuming process that can delay patient care. However, recent reforms have shown promising developments, including UnitedHealthcare’s Gold Card program, which eases authorization requirements for high-performing physicians. Although this initiative currently applies only to Medicare Advantage plans, ASNC is pushing for wider adoption to reduce administrative burdens across the board.
Keeping Up to Date with Cardiology Medical Billing Best Practices
Staying informed about the latest policies, codes, and reimbursement strategies is crucial for anyone involved in cardiology medical billing. ASNC has published a comprehensive resource—Medicare Reimbursement for Positron Emission Tomography (PET) Scans: The Importance of Charges and Cost-to-Charge Ratios—which dives deep into how CMS sets reimbursement rates and why accurate cost reporting is essential.
Whether you’re a clinician aiming to justify new technology adoption or an administrator tasked with ensuring financial viability, remaining up-to-date on these evolving guidelines helps maintain both high-quality patient care and a stable revenue cycle.
Final Thoughts
Understanding hospital billing for cardiac PET/CT is no small feat, but it’s a critical component of delivering quality care and maintaining financial health. By accurately reporting costs, actively participating in advocacy efforts, and staying abreast of the latest reforms and guidelines, healthcare providers can more confidently navigate this intricate landscape.
For additional information and insights, visit Cardiovascular Business, which contributed much of the source material for this summary.